Skip to main content
. Author manuscript; available in PMC: 2020 Mar 27.
Published in final edited form as: J Allergy Clin Immunol. 2019 Sep 13;145(1):229–238. doi: 10.1016/j.jaci.2019.08.036

Fig 5.

Fig 5

T cell–stimulating abilities of Ara h 2 derivatives. A, In vitro proliferation assays with PBMCs from Ara h 2–sensitized patients with peanut allergy (n = 9). Data are presented as relative SIs normalized to the SIs of cells treated with nAra h 2. B, Flow cytometry–based proliferation assay with PBMCs of a representative patient. Data represent percentages of proliferating (carboxyfluorescein N-succinimidyl ester–low) cells among CD4+ T cells (CD3+CD8− cells).